Obesity Therapeutic Drugs Market Report

China Obesity Therapeutic Drugs Industry Market Research Report 2023-2029

  • POSTDATE：Sep 17, 2023
  • PAGES：215
  • REPORT CODE：GMM1804213
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Obesity Therapeutic Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Shionogi

    • GlaxoSmithKline

    • Takeda Pharmaceutical

    • Vivus

    • Sanofi

    • Orexigen Therapeutics

    • Novo Nordisk

    • Eisai

    • Norgine

    By Type:

    • Type 1

    • Type 2

    • Type 3

    By Application:

    • Application 1

    • Application 2

    • Application 3

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Obesity Therapeutic Drugs Market Overview 2018-2029

    • 1.1 China Obesity Therapeutic Drugs Industry Development Overview

    • 1.2 China Obesity Therapeutic Drugs Industry Development History

    • 1.3 China Obesity Therapeutic Drugs Industry Market Size (2018-2029)

    • 1.4 China Obesity Therapeutic Drugs Market Analysis by Type from Production Side

      • 1.4.1 China Obesity Therapeutic Drugs Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)

      • 1.4.2 China Obesity Therapeutic Drugs Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)

      • 1.4.3 China Obesity Therapeutic Drugs Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)

    • 1.5 China Obesity Therapeutic Drugs Market Analysis by Application from Consumption End

      • 1.5.1 China Obesity Therapeutic Drugs Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)

      • 1.5.2 China Obesity Therapeutic Drugs Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)

      • 1.5.3 China Obesity Therapeutic Drugs Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)

    • 1.6 China Obesity Therapeutic Drugs Market Analysis by Region

      • 1.6.1 North China Obesity Therapeutic Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Obesity Therapeutic Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Obesity Therapeutic Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Obesity Therapeutic Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Obesity Therapeutic Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Obesity Therapeutic Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Obesity Therapeutic Drugs Market Size and Growth Rate from 2018-2029

    Chapter 2 China Obesity Therapeutic Drugs Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Obesity Therapeutic Drugs Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Obesity Therapeutic Drugs Market Status and Competition Analysis in 2023

      • 2.2.3 China Obesity Therapeutic Drugs Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Obesity Therapeutic Drugs Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Obesity Therapeutic Drugs Industry Development

    Chapter 3 Obesity Therapeutic DrugsIndustry Chain Analysis

    • 3.1 Obesity Therapeutic Drugs Industry Chain

    • 3.2 Obesity Therapeutic Drugs Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Obesity Therapeutic Drugs Market

    • 3.3 Obesity Therapeutic Drugs Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Obesity Therapeutic Drugs Market

    Chapter 4 China Obesity Therapeutic Drugs Market, by Type

    • 4.1 China Obesity Therapeutic Drugs Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Obesity Therapeutic Drugs Total Production Volume and Growth Rate from Production Side

    • 4.5 China Obesity Therapeutic Drugs Production Volume and Growth Rate, by Type

      • 4.5.1 China Obesity Therapeutic Drugs Production Volume and Growth Rate of Type 1

      • 4.5.2 China Obesity Therapeutic Drugs Production Volume and Growth Rate of Type 2

      • 4.5.3 China Obesity Therapeutic Drugs Production Volume and Growth Rate of Type 3

    Chapter 5 China Obesity Therapeutic Drugs Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Obesity Therapeutic Drugs Total Market Size and Growth Rate from Consumption End

    • 5.5 China Obesity Therapeutic Drugs Market Size and Growth Rate, by Application

      • 5.5.1 China Obesity Therapeutic Drugs Market Size and Growth Rate of Application 1

      • 5.5.2 China Obesity Therapeutic Drugs Market Size and Growth Rate of Application 2

      • 5.5.3 China Obesity Therapeutic Drugs Market Size and Growth Rate of Application 3

    Chapter 6 China Obesity Therapeutic Drugs Market, by Region

    • 6.1 China Obesity Therapeutic Drugs Production Volume and Production Value, by Region

    • 6.2 China Obesity Therapeutic Drugs Sales Volume and Sales Value, by Region

    Chapter 7 North China Obesity Therapeutic Drugs Market Analysis

    • 7.1 North China Obesity Therapeutic Drugs Market, by Type

    • 7.2 North China Obesity Therapeutic Drugs Market, by Application

    Chapter 8 Central China Obesity Therapeutic Drugs Market Analysis

    • 8.1 Central China Obesity Therapeutic Drugs Market, by Type

    • 8.2 Central China Obesity Therapeutic Drugs Market, by Application

    Chapter 9 South China Obesity Therapeutic Drugs Market Analysis

    • 9.1 South China Obesity Therapeutic Drugs Market, by Type

    • 9.2 South China Obesity Therapeutic Drugs Market, by Application

    Chapter 10 East China Obesity Therapeutic Drugs Market Analysis

    • 10.1 East China Obesity Therapeutic Drugs Market, by Type

    • 10.2 East China Obesity Therapeutic Drugs Market, by Application

    Chapter 11 Northeast China Obesity Therapeutic Drugs Market Analysis

    • 11.1 Northeast China Obesity Therapeutic Drugs Market, by Type

    • 11.2 Northeast China Obesity Therapeutic Drugs Market, by Application

    Chapter 12 Southwest China Obesity Therapeutic Drugs Market Analysis

    • 12.1 Southwest China Obesity Therapeutic Drugs Market, by Type

    • 12.2 Southwest China Obesity Therapeutic Drugs Market, by Application

    Chapter 13 Northwest China Obesity Therapeutic Drugs Market Analysis

    • 13.1 Northwest China Obesity Therapeutic Drugs Market, by Type

    • 13.2 Northwest China Obesity Therapeutic Drugs Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Shionogi

        • 14.1.1 Shionogi Company Profile

        • 14.1.2 Shionogi Obesity Therapeutic Drugs Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 GlaxoSmithKline

        • 14.2.1 GlaxoSmithKline Company Profile

        • 14.2.2 GlaxoSmithKline Obesity Therapeutic Drugs Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Takeda Pharmaceutical

        • 14.3.1 Takeda Pharmaceutical Company Profile

        • 14.3.2 Takeda Pharmaceutical Obesity Therapeutic Drugs Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Vivus

        • 14.4.1 Vivus Company Profile

        • 14.4.2 Vivus Obesity Therapeutic Drugs Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Sanofi

        • 14.5.1 Sanofi Company Profile

        • 14.5.2 Sanofi Obesity Therapeutic Drugs Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Orexigen Therapeutics

        • 14.6.1 Orexigen Therapeutics Company Profile

        • 14.6.2 Orexigen Therapeutics Obesity Therapeutic Drugs Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Novo Nordisk

        • 14.7.1 Novo Nordisk Company Profile

        • 14.7.2 Novo Nordisk Obesity Therapeutic Drugs Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Eisai

        • 14.8.1 Eisai Company Profile

        • 14.8.2 Eisai Obesity Therapeutic Drugs Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Norgine

        • 14.9.1 Norgine Company Profile

        • 14.9.2 Norgine Obesity Therapeutic Drugs Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Obesity Therapeutic Drugs Industry Research Conclusions

    • 15.2 Obesity Therapeutic Drugs Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Obesity Therapeutic Drugs Industry Market Size (2018-2029)

    • Figure China Obesity Therapeutic Drugs Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)

    • Figure China Obesity Therapeutic Drugs Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)

    • Figure China Obesity Therapeutic Drugs Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)

    • Figure China Obesity Therapeutic Drugs Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)

    • Figure China Obesity Therapeutic Drugs Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)

    • Figure China Obesity Therapeutic Drugs Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)

    • Figure North China Obesity Therapeutic Drugs Market Size and Growth Rate from 2018-2029

    • Figure Central China Obesity Therapeutic Drugs Market Size and Growth Rate from 2018-2029

    • Figure South China Obesity Therapeutic Drugs Market Size and Growth Rate from 2018-2029

    • Figure East China Obesity Therapeutic Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Obesity Therapeutic Drugs Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Obesity Therapeutic Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Obesity Therapeutic Drugs Market Size and Growth Rate from 2018-2029

    • Figure Obesity Therapeutic Drugs Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Obesity Therapeutic Drugs Market Share by Type in 2018

    • Figure China Obesity Therapeutic Drugs Market Share by Type in 2023

    • Figure China Obesity Therapeutic Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Obesity Therapeutic Drugs Production Volume and Growth Rate of Type 1 (2018-2023)

    • Figure China Obesity Therapeutic Drugs Production Volume and Growth Rate of Type 2 (2018-2023)

    • Figure China Obesity Therapeutic Drugs Production Volume and Growth Rate of Type 3 (2018-2023)

    • Figure China Obesity Therapeutic Drugs Market Share by Application in 2018

    • Figure China Obesity Therapeutic Drugs Market Share by Application in 2023

    • Figure China Obesity Therapeutic Drugs Total Market Size and Growth Rate from Consumption End

    • Figure China Obesity Therapeutic Drugs Market Size and Growth Rate of Application 1 (2018-2023)

    • Figure China Obesity Therapeutic Drugs Market Size and Growth Rate of Application 2 (2018-2023)

    • Figure China Obesity Therapeutic Drugs Market Size and Growth Rate of Application 3 (2018-2023)

    • Table China Obesity Therapeutic Drugs Production Volume by Region (2018-2023)

    • Table China Obesity Therapeutic Drugs Production Volume Share by Region (2018-2023)

    • Figure China Obesity Therapeutic Drugs Production Volume Share by Region (2018-2023)

    • Table China Obesity Therapeutic Drugs Production Value by Region (2018-2023)

    • Table China Obesity Therapeutic Drugs Production Value Share by Region (2018-2023)

    • Figure China Obesity Therapeutic Drugs Production Value Share by Region (2018-2023)

    • Table China Obesity Therapeutic Drugs Sales Volume by Region (2018-2023)

    • Table China Obesity Therapeutic Drugs Sales Volume Share by Region (2018-2023)

    • Figure China Obesity Therapeutic Drugs Sales Volume Share by Region (2018-2023)

    • Table China Obesity Therapeutic Drugs Sales Value by Region (2018-2023)

    • Table China Obesity Therapeutic Drugs Sales Value Share by Region (2018-2023)

    • Figure China Obesity Therapeutic Drugs Sales Value Share by Region (2018-2023)

    • Table North China Obesity Therapeutic Drugs Production Volume by Type (2018-2023)

    • Table North China Obesity Therapeutic Drugs Production Volume Share by Type (2018-2023)

    • Figure North China Obesity Therapeutic Drugs Production Volume Share by Type (2018-2023)

    • Table North China Obesity Therapeutic Drugs Sales Volume by Application (2018-2023)

    • Table North China Obesity Therapeutic Drugs Sales Volume Share by Application (2018-2023)

    • Figure North China Obesity Therapeutic Drugs Sales Volume Share by Application (2018-2023)

    • Table Central China Obesity Therapeutic Drugs Production Volume by Type (2018-2023)

    • Table Central China Obesity Therapeutic Drugs Production Volume Share by Type (2018-2023)

    • Figure Central China Obesity Therapeutic Drugs Production Volume Share by Type (2018-2023)

    • Table Central China Obesity Therapeutic Drugs Sales Volume by Application (2018-2023)

    • Table Central China Obesity Therapeutic Drugs Sales Volume Share by Application (2018-2023)

    • Figure Central China Obesity Therapeutic Drugs Sales Volume Share by Application (2018-2023)

    • Table South China Obesity Therapeutic Drugs Production Volume by Type (2018-2023)

    • Table South China Obesity Therapeutic Drugs Production Volume Share by Type (2018-2023)

    • Figure South China Obesity Therapeutic Drugs Production Volume Share by Type (2018-2023)

    • Table South China Obesity Therapeutic Drugs Sales Volume by Application (2018-2023)

    • Table South China Obesity Therapeutic Drugs Sales Volume Share by Application (2018-2023)

    • Figure South China Obesity Therapeutic Drugs Sales Volume Share by Application (2018-2023)

    • Table East China Obesity Therapeutic Drugs Production Volume by Type (2018-2023)

    • Table East China Obesity Therapeutic Drugs Production Volume Share by Type (2018-2023)

    • Figure East China Obesity Therapeutic Drugs Production Volume Share by Type (2018-2023)

    • Table East China Obesity Therapeutic Drugs Sales Volume by Application (2018-2023)

    • Table East China Obesity Therapeutic Drugs Sales Volume Share by Application (2018-2023)

    • Figure East China Obesity Therapeutic Drugs Sales Volume Share by Application (2018-2023)

    • Table Northeast China Obesity Therapeutic Drugs Production Volume by Type (2018-2023)

    • Table Northeast China Obesity Therapeutic Drugs Production Volume Share by Type (2018-2023)

    • Figure Northeast China Obesity Therapeutic Drugs Production Volume Share by Type (2018-2023)

    • Table Northeast China Obesity Therapeutic Drugs Sales Volume by Application (2018-2023)

    • Table Northeast China Obesity Therapeutic Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Obesity Therapeutic Drugs Sales Volume Share by Application (2018-2023)

    • Table Southwest China Obesity Therapeutic Drugs Production Volume by Type (2018-2023)

    • Table Southwest China Obesity Therapeutic Drugs Production Volume Share by Type (2018-2023)

    • Figure Southwest China Obesity Therapeutic Drugs Production Volume Share by Type (2018-2023)

    • Table Southwest China Obesity Therapeutic Drugs Sales Volume by Application (2018-2023)

    • Table Southwest China Obesity Therapeutic Drugs Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Obesity Therapeutic Drugs Sales Volume Share by Application (2018-2023)

    • Table Northwest China Obesity Therapeutic Drugs Production Volume by Type (2018-2023)

    • Table Northwest China Obesity Therapeutic Drugs Production Volume Share by Type (2018-2023)

    • Figure Northwest China Obesity Therapeutic Drugs Production Volume Share by Type (2018-2023)

    • Table Northwest China Obesity Therapeutic Drugs Sales Volume by Application (2018-2023)

    • Table Northwest China Obesity Therapeutic Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Obesity Therapeutic Drugs Sales Volume Share by Application (2018-2023)

    • Table Shionogi Company Profile

    • Table Shionogi Obesity Therapeutic Drugs Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Company Profile

    • Table GlaxoSmithKline Obesity Therapeutic Drugs Revenue, Price and Gross (2018-2023)

    • Table Takeda Pharmaceutical Company Profile

    • Table Takeda Pharmaceutical Obesity Therapeutic Drugs Revenue, Price and Gross (2018-2023)

    • Table Vivus Company Profile

    • Table Vivus Obesity Therapeutic Drugs Revenue, Price and Gross (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi Obesity Therapeutic Drugs Revenue, Price and Gross (2018-2023)

    • Table Orexigen Therapeutics Company Profile

    • Table Orexigen Therapeutics Obesity Therapeutic Drugs Revenue, Price and Gross (2018-2023)

    • Table Novo Nordisk Company Profile

    • Table Novo Nordisk Obesity Therapeutic Drugs Revenue, Price and Gross (2018-2023)

    • Table Eisai Company Profile

    • Table Eisai Obesity Therapeutic Drugs Revenue, Price and Gross (2018-2023)

    • Table Norgine Company Profile

    • Table Norgine Obesity Therapeutic Drugs Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US